Inferra AI / Company / AHCO
AdaptHealth Corp.
AHCO · Health Care
Last earnings Aug 4, 2026
Key results
Net revenuequarter
$800.4 million
Net revenue was $800.4 million compared to $806.0 million, a decrease of 0.7%.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Net incomequarter
$14.7 million
was $14.7 million compared to net income of $19.4 million.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Free cash flowytd
$73.3 million
Cash flow from operations was $257.5 million year-to-date 2025, an increase from $247.0 million during the comparable period in 2024, and free cash flow was $73.3 million year-to-date 2025, compared to $77.9 million during the comparable period in 2024.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
AI analysis
Q2 2025 · reported Aug 5, 2025
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
The quarter in charts
Guidance ladder — revenue
Delivered vs the company's guided range
EX-99 · Aug 5, 2025 Guide as stated by the company; range and midpoint computed from the stated figure.
Headline figures
| Metric | Q2 2025 | Prior qtr | Year ago |
|---|---|---|---|
| Net revenue | $800.4 million | — | — |
| Net income | $14.7 million | — | — |
Guidance · company-stated
Direction: Reiterated
“Financial Outlook The Company is updating previous financial guidance for fiscal year 2025, as follows Net revenue of $3.18 billion to $3.26 billion, from $3.15 billion to $3.29 billion Adjusted EBITDA of $642 million to $682 million, from $662 million to $702 million Free cash flow of $170 million to $190 million, unchanged Conference Call Management will host a teleconference today, Tuesday, August 5, 2025, at 8 30 am ET to discuss the results and business activities with analysts and investors.”
Classified from the release's primary full-year outlook statement.
Cash flow & capex
Capital allocation
And we are making rapid progress reducing debt and fortifying our financial position.
GAAP, in its operational and financial decision-making and believes free cash flow is useful to investors because similar measures are frequently used by securities analysts, investors, ratings agencies and other interested parties to evaluate the Company's competitors and to measure the ability of companies to service their debt.
What changed vs last quarter
- Guide midpoint vs latest-quarter revenue +297.3% computed from stated figures
Event summary
ANNOUNCES SECOND QUARTER 2025 RESULTS
Based on: Earnings release + parent 8-K + 10-Q — transcript not held
Guidance & outlook
Direction: Reiterated
Revenue: “Financial Outlook The Company is updating previous financial guidance for fiscal year 2025, as follows Net revenue of $3.18 billion to $3.26 billion, from $3.15 billion to $3.29 billion Adjusted EBITDA of $642 million to $682 million, from $662 million to $702 million Free cash flow of $170 million to $190 million, unchanged Conference Call Management will host a teleconference today, Tuesday, August 5, 2025, at 8 30 am ET to discuss the results and business activities with analysts and investors.”
Revenue — Reiterated (“unchanged”)
“Financial Outlook The Company is updating previous financial guidance for fiscal year 2025, as follows Net revenue of $3.18 billion to $3.26 billion, from $3.15 billion to $3.29 billion Adjusted EBITDA of $642 million to $682 million, from $662 million to $702 million Free cash flow of $170 million to $190 million, unchanged Conference Call Management will host a teleconference today, Tuesday, August 5, 2025, at 8 30 am ET to discuss the results and business activities with analysts and investors.”
Classified from the release's primary full-year outlook statement.
Capital allocation
And we are making rapid progress reducing debt and fortifying our financial position.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
GAAP, in its operational and financial decision-making and believes free cash flow is useful to investors because similar measures are frequently used by securities analysts, investors, ratings agencies and other interested parties to evaluate the Company's competitors and to measure the ability of companies to service their debt.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
The Company does not have any material bad debt expense.
SEC original ↗AdaptHealth Corp. — 10-Q Quarterly report10-QAug 4, 2026
Strategy & priorities
We are advancing multiple initiatives to boost operating efficiency, elevate the patient experience, and expand our profit margins.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
The Company's presentation of free cash flow should not be construed as a measure of liquidity or discretionary cash available to the Company to fund its cash needs, including investing in the growth of its business and meeting its obligations.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
In addition, the Company s financial guidance in this release excludes the impact of any potential additional future strategic acquisitions and any items that have not yet been identified and quantified.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
These forward-looking statements relate to expectations for future financial performance, business strategies or expectations for our business.
SEC original ↗AdaptHealth Corp. — 10-Q Quarterly report10-QAug 4, 2026
(h) Gain or Loss on Disposals From time to time, the Company may sell individual businesses when doing so aligns with its strategic priorities.
SEC original ↗AdaptHealth Corp. — 10-Q Quarterly report10-QAug 4, 2026
Risks & headwinds
These forward-looking statements are subject to a number of risks and uncertainties, including the outcome of judicial and administrative proceedings to which the Company may become a party or governmental investigations to which the Company may become subject that could interrupt or limit the Company s operations, result in adverse judgments, settlements or fines and create negative publicity changes in the Company s customers preferences, prospects and the competitive conditions prevailing in the healthcare sector.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
A further description of such risks and uncertainties can be found in the Company s filings with the Securities and Exchange Commission.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
The financial guidance is subject to risks and uncertainties applicable to all forward-looking statements as described elsewhere in this press release.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
AdaptHealth defines Adjusted EBITDA as EBITDA (as defined above), plus equity-based compensation expense, change in fair value of the warrant liability, goodwill impairment, litigation settlement expense (gain), gain on sale of businesses, and certain other non-recurring items of expense or income.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
The 2024 period consists of $5.8 million of consulting expenses associated with systems implementation activities, $1.6 million of expenses associated with litigation, a $0.9 million write-down of assets, $0.3 million of consulting expenses associated with asset dispositions, and $1.7 million of other non-recurring expenses.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
The 2024 period consists of $6.9 million of consulting expenses associated with systems implementation activities, $2.8 million of expenses associated with litigation, a $1.6 million write-down of assets, $0.9 million of consulting expenses associated with asset dispositions, and $2.2 million of other non-recurring expenses.
SEC original ↗AdaptHealth Corp. — Earnings release (8-K exhibit)EX-99Aug 5, 2025
Competitors
Competitors & peers
Same GICS sector — classification peers, not declared competitors
Filings
31 documents- Q2 2026
- 8-KAHCO
Sep 8, 2026
- 8-KAHCO
Aug 4, 2026
- 10-QAHCO
Aug 4, 2026
- 8-KAHCO
Jul 20, 2026
- 8-KAHCO
Jul 7, 2026
- 8-KAHCO
Jul 2, 2026
- Q1 2026
- 8-KAHCO
Jun 22, 2026
- 8-K/AAHCO
Jun 2, 2026
- 8-KAHCO
May 5, 2026
- 10-QAHCO
May 5, 2026
- 8-KAHCO
Apr 13, 2026
- EX-99AHCO
Apr 13, 2026
- Q4 2025
- 8-KAHCO
Feb 24, 2026
- 10-KAHCO
Feb 24, 2026
- Q3 2025
- 8-KAHCO
Nov 4, 2025
- 10-QAHCO
Nov 4, 2025
- Q2 2025
- 8-KAHCO
Aug 5, 2025
- 8-KAHCO
Aug 5, 2025
- 10-QAHCO
Aug 5, 2025
- Q1 2025
- 8-KAHCO
Jun 30, 2025
- 8-KAHCO
Jun 20, 2025
- 8-KAHCO
May 6, 2025
- 10-QAHCO
May 6, 2025
- Q4 2024
- 8-KAHCO
Feb 25, 2025
- 10-KAHCO
Feb 25, 2025
- Q3 2024
- 8-KAHCO
Dec 13, 2024
- 8-KAHCO
Nov 5, 2024
- 10-QAHCO
Nov 5, 2024
- 8-KAHCO
Oct 30, 2024
- 8-KAHCO
Oct 22, 2024
- Q2 2024
- 8-KAHCO
Sep 30, 2024
Earnings releases
10 documentsPresentations
0 documentsNo presentations for AdaptHealth Corp. are held in this edition of the library.
Transcripts
0 documentsNo transcripts for AdaptHealth Corp. are held in this edition of the library.
Mentioned by
1 companyOther tracked companies whose held documents mention AdaptHealth Corp. by name or ticker. A mention is counted once per document, from the document text the library holds.
“f Strive Medical and the announced tuck-in acquisition of the Diabetes Health business of AdaptHealth.… …239 67 % $ 1,714 $ 1,561 10 % Earnings per common share attributable to Cardinal Health, Inc.: Basic $ 1.70 $ 1.01 68 % $ 7.27 $ 6.48 12 % ”
See also the earnings calendar for every tracked company’s next earnings date.